ABSTRACT
The management of erythromelalgia is challenging and requires multidisciplinary effort. Patient education is crucial as unsafe self-administered cooling techniques can lead to significant morbidity, including acral necrosis, infection, and amputation. The goal of management is pain control, reduction of flare frequency, and prevention of complications. This text is focused on the management of erythromelalgia and several other incompletely understood and under-recognized neurovascular disorders such as red scrotum syndrome, red ear syndrome, facial flushing, and complex regional pain syndrome.
Subject(s)
Erythromelalgia , Genital Diseases, Male , Male , Humans , Erythromelalgia/diagnosis , Erythromelalgia/therapy , Erythromelalgia/complications , Diagnosis, Differential , Syndrome , Amputation, SurgicalABSTRACT
Erythromelalgia is a rare syndrome characterised by recurrent erythema, heat and burning pain in the extremities. There are two types: primary (genetic) and secondary (toxic, drug-related or associated with other diseases). We report a 42-year-old woman who developed erythromelalgia after taking cyclosporine for myasthenia gravis. Although exact mechanism for this rare adverse effect is unclear, it is reversible, and so clinicians should be aware of the association . Additional use of corticosteroids could aggravate cyclosporine's toxic effects.
Subject(s)
Erythromelalgia , Female , Humans , Adult , Erythromelalgia/chemically induced , Erythromelalgia/diagnosis , Erythromelalgia/complications , Cyclosporine/adverse effects , PainABSTRACT
Erythromelalgia is a rare neurovascular disorder characterized by erythema, warmth, and episodic burning pain, often felt in the face, hands, and feet. Symptoms are typically worse with heat, exercise, stress, and during the overnight hours. Management often requires a multidisciplinary approach, including pain trigger avoidance, cool water baths, and topical and oral neuropathic medications. The use of spinal cord stimulation has been described in multiple case reports with success reported out to 24Ā months. To our knowledge, the use of dorsal root ganglion (DRG) stimulation for erythromelalgia-related pain has not been described. Herein, we present a case of erythromelalgia-related pain at the bilateral plantar surfaces of the feet, which was treated successfully with bilateral sacral S1 nerve root DRG stimulation.
Subject(s)
Erythromelalgia , Spinal Cord Stimulation , Erythromelalgia/complications , Erythromelalgia/diagnosis , Erythromelalgia/therapy , Foot , Ganglia, Spinal , Humans , Pain/etiologyABSTRACT
INTRODUCTION: Small-fiber neuropathy is rare in children. It has been associated with several autoimmune disorders, but there are no reports of an autoinflammatory etiology. METHODS: The data of four children/adolescents presenting with erythromelalgia and neuropathic pain from 2014 to 2019 were collected retrospectively from the electronic database of a pediatric medical center. RESULTS: Results of clinical and/or electrophysiological evaluation excluded large nerve fiber involvement. Skin biopsy results confirmed small-fiber neuropathy. According to genetic analysis, two patients were heterozygous and one was homozygous for mutations in the familial Mediterranean fever (MEFV) gene. Behcet disease was diagnosed in the fourth patient. Treatment with anti-interleukin-1 agents, intravenous immunoglobulin, and glucocorticoids was beneficial. DISCUSSION: The diagnosis of small-fiber neuropathy should be considered in children/adolescents presenting with erythromelalgia. A thorough investigation is required to reveal the underlying disorder. Clinicians should be alert to the peripheral neurological manifestations of autoinflammatory syndromes because effective treatments are available.
Subject(s)
Erythromelalgia/complications , Erythromelalgia/diagnosis , Small Fiber Neuropathy/complications , Small Fiber Neuropathy/diagnosis , Adolescent , Autoimmune Diseases/complications , Autoimmune Diseases/diagnosis , Autoimmune Diseases/physiopathology , Child , Erythromelalgia/physiopathology , Female , Humans , Inflammation/complications , Inflammation/diagnosis , Inflammation/physiopathology , Retrospective Studies , Small Fiber Neuropathy/physiopathology , SyndromeABSTRACT
OBJECTIVES: To evaluate the clinical features of erythromelalgia in childhood associated with gain-of-function SCN9A mutations that increase activity of the Nav1.7 voltage-gated sodium channel, we conducted a systematic review of pediatric presentations of erythromelalgia related to SCN9A mutations, and compared pediatric clinical presentations of symptomatic erythromelalgia, with or without SCN9A mutations. STUDY DESIGN: PubMed, Embase, and PsycINFO Databases were searched for reports of inherited erythromelalgia in childhood. Clinical features, management, and genotype were extracted. Case notes of pediatric patients with erythromelalgia from the Great Ormond Street Hospital Pain Service were reviewed for clinical features, patient-reported outcomes, and treatments. Children aged over 10 years were recruited for quantitative sensory testing. RESULTS: Twenty-eight publications described erythromelalgia associated with 15 different SCN9A gene variants in 25 children. Pain was severe and often refractory to multiple treatments, including nonspecific sodium channel blockers. Skin damage or other complications of cold immersion for symptomatic relief were common (60%). SCN9A mutations resulting in greater hyperpolarizing shifts in Nav1.7 sodium channels correlated with symptom onset at younger ages (P = .016). Variability in reporting, and potential publication bias toward severe cases, limit any estimations of overall prevalence. In our case series, symptoms were similar but comorbidities were more common in children with SCN9A mutations. Quantitative sensory testing revealed marked dynamic warm allodynia. CONCLUSIONS: Inherited erythromelalgia in children is associated with difficult-to-manage pain and significant morbidity. Standardized reporting of outcome and management in larger series will strengthen identification of genotype-phenotype relationships. More effective long-term therapies are a significant unmet clinical need.
Subject(s)
Erythromelalgia/complications , Erythromelalgia/genetics , Mutation/genetics , NAV1.7 Voltage-Gated Sodium Channel/genetics , Pain/etiology , Adolescent , Child , Female , Humans , Male , Retrospective Studies , Symptom AssessmentSubject(s)
Erythromelalgia , Pachyonychia Congenita , Humans , Pachyonychia Congenita/complications , Pachyonychia Congenita/genetics , Pachyonychia Congenita/diagnosis , Female , Male , Cross-Sectional Studies , Erythromelalgia/diagnosis , Erythromelalgia/complications , Adult , Adolescent , Young Adult , Child , Middle AgedABSTRACT
Erythromelalgia is a condition characterized by episodic pain, erythema and temperature of the extremities, which is relieved by cooling and aggravated by warming. It is useful to review this topic in light of recent discoveries of the genetic mutations that now define primary erythromelalgia, as opposed to secondary erythromelalgia, which is often associated with underlying medical disorders.
Subject(s)
Erythromelalgia/diagnosis , Capsaicin/therapeutic use , Erythromelalgia/complications , Erythromelalgia/genetics , Erythromelalgia/therapy , Humans , Mass Screening , Mexiletine/therapeutic use , Myeloproliferative Disorders/complications , Myeloproliferative Disorders/diagnosis , NAV1.7 Voltage-Gated Sodium Channel/genetics , Ranolazine/therapeutic use , Sensory System Agents/therapeutic use , Sodium Channel Blockers/therapeutic use , SympathectomyABSTRACT
OBJECTIVES: To review our clinical experience of this rare condition and describe the clinical features and response to therapy in a cohort of patients with erythromelalgia (EM), a rare condition, characterised by paroxysmal hyperthermia of the extremities with erythema, pain and intense burning. METHODS: A review was made of the electronic and paper medical records of patients with the diagnosis of EM, with a telephone interview to verify and complete clinical information relating treatment and outcome. RESULTS: 46 patients (41 females) were included in this study. Mean age was 57 years and mean duration of symptoms was 16 years. Raynaud's phenomenon was present in 36 patients (80%) and 4 patients (9%) had systemic sclerosis. Smoking (current or previous) was identified as a possible risk factor in 26 cases and exposure to chronic vibration in 3 cases. Overall, the effect on quality of life was mild in 15% of cases, moderate in 30% and severe in 48%. The most common symptoms were burning (96%), heat (93%), pain (87%), and redness (83%). Symptoms affected the lower limbs in 98% of cases, upper limbs in 76%, face in 20% and trunk in 11%. Triggers included heat (85%), exercise (78%) and time of day (76%). Various medications were tried, showing poor effect in most cases. Intravenous iloprost was given to 27 patients, with benefit in 17 patients (63%). CONCLUSIONS: Erythromelalgia is a rare chronic debilitating condition. Exercise, heat and night time are common triggers. Current medical therapies are seldom effective and further research is sorely needed.
Subject(s)
Erythromelalgia/diagnosis , Erythromelalgia/drug therapy , Iloprost/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Adult , Erythromelalgia/complications , Female , Follow-Up Studies , Humans , Male , Middle Aged , Quality of Life , Raynaud Disease/complications , Risk Factors , Smoking , Symptom Assessment , Treatment OutcomeABSTRACT
Erythromelalgia is a rare disorder characterized by burning pain, erythema, and increased temperature typically involving the distal extremities. Although it can progress to involve the face, erythromelalgia presenting only on the face is particularly rare. This disorder is often misdiagnosed when it presents on the extremities and is even more likely to be misdiagnosed when presenting only on the face, delaying appropriate treatment and causing considerable frustration for the patient. We report a case of a 26-year-old woman with erythromelalgia that involved only the face for a number of years and was treated unsuccessfully as rosacea, seborrheic dermatitis, and contact dermatitis. She subsequently developed involvement of the ears and hands in the more typical distribution of erythromelalgia. We discuss the differential diagnosis of erythromelalgia involving the face and extremities, the proposed pathogenesis and management of the disorder, and the psychological distress this condition can cause. Even when the correct diagnosis of erythromelalgiais made, treatment is difficult, with no single therapy consistently effective.
Subject(s)
Erythromelalgia/complications , Erythromelalgia/diagnosis , Facial Dermatoses/etiology , Hand Dermatoses/etiology , Adult , Erythromelalgia/drug therapy , Female , HumansABSTRACT
AIM: To investigate whether AĆĀ“ and C fibre pain threshold values, measured using intra-epidermal electrical stimulation (IES), in people with and without Type 2 diabetes are useful in evaluating diabetic polyneuropathy (DPN) severity. METHODS: AĆĀ“ and C fibre pain threshold values were measured in Japanese people with (n = 120) and without (n = 76) Type 2 diabetes by IES. Nerve conduction studies and other tests were performed to evaluate diabetic complications. RESULTS: AĆĀ“ and C fibre pain threshold values were high in people with diabetes compared with control subjects (AĆĀ“ fibre: 0.050 vs. 0.030 mA, P < 0.01; C fibre: 0.180 vs. 0.070 mA, P < 0.01). Participants with diabetes and neuropathy had significantly higher AĆĀ“ and C fibre pain threshold values than participants without neuropathy (AĆĀ“ fibres 0.063 vs. 0.039 mA, P < 0.01; C fibres 0.202 vs. 0.098 mA, P < 0.05). C fibre pain threshold values were significantly higher in participants with diabetes and diabetic microvascular complications than in participants without complications. Threshold values increased with complication progression. When DPN was diagnosed according to the Diabetic Neuropathy Study Group in Japan criteria, the cut-off for the C fibre pain threshold values was 0.125 mA (area under the curve 0.758, sensitivity 81.5%, specificity 61.5%). The IES test took less time (P < 0.01) and was less invasive (P < 0.01) than the nerve conduction studies. CONCLUSIONS: Intra-epidermal electrical stimulation is a non-invasive and easy measurement of small fibre pain threshold values. It may be clinically useful for C fibre measurement to diagnose early DPN as defined by the Diabetic Neuropathy Study Group in Japan criteria.
Subject(s)
Diabetes Mellitus, Type 2/complications , Diabetic Angiopathies/diagnosis , Diabetic Neuropathies/diagnosis , Erythromelalgia/diagnosis , Nerve Fibers, Unmyelinated/metabolism , Pain Threshold , Polyneuropathies/diagnosis , Diabetic Angiopathies/complications , Diabetic Angiopathies/metabolism , Diabetic Angiopathies/physiopathology , Diabetic Nephropathies/complications , Diabetic Nephropathies/physiopathology , Diabetic Neuropathies/complications , Diabetic Neuropathies/metabolism , Diabetic Neuropathies/physiopathology , Diabetic Retinopathy/complications , Diabetic Retinopathy/physiopathology , Dyslipidemias/complications , Dyslipidemias/epidemiology , Early Diagnosis , Electric Stimulation/instrumentation , Epidermis , Erythromelalgia/complications , Erythromelalgia/metabolism , Erythromelalgia/physiopathology , Female , Humans , Hypertension/complications , Hypertension/epidemiology , Japan/epidemiology , Male , Middle Aged , Point-of-Care Testing , Polyneuropathies/complications , Polyneuropathies/metabolism , Polyneuropathies/physiopathology , Prevalence , Sensitivity and Specificity , Severity of Illness IndexABSTRACT
Etiological and clinical heterogeneity of small fiber neuropathy (SFN) precludes a unifying approach and necessitates reliance on recognizable clinical syndromes. Symptoms of SFN arise from dysfunction in nociception, temperature, and autonomic modalities. This review focuses on SFN involving nociception and temperature, examining epidemiology, etiology, clinical presentation, diagnosis, pathophysiology, and management. Prevalence of SFN is 52.95 per 100,000 population, and diabetes and idiopathic are the most common etiologies. Dysesthesia, allodynia, pain, burning, and coldness sensations frequently present in a length-dependent pattern. Additional autonomic features in gastrointestinal, urinary, or cardiovascular systems are frequent but poorly objectified. SFN is diagnosed by intraepidermal nerve fiber density and quantitative sensory and autonomic tests in combination with normal nerve conduction. Pathophysiological understanding centers on sodium channel dysfunction, and genetic forms are beginning to be understood. Treatment is directed at the underlying etiology supported by symptomatic treatment using antidepressants and anticonvulsants. Little is known about long-term outcomes, and systematic cohort studies are needed.
Subject(s)
Autonomic Nervous System Diseases/physiopathology , Diabetic Neuropathies/physiopathology , Erythromelalgia/physiopathology , Hyperalgesia/physiopathology , Paresthesia/physiopathology , Anticonvulsants/therapeutic use , Antidepressive Agents/therapeutic use , Autonomic Nervous System Diseases/etiology , Diabetic Neuropathies/epidemiology , Diabetic Neuropathies/therapy , Disease Management , Erythromelalgia/complications , Erythromelalgia/epidemiology , Erythromelalgia/therapy , Humans , Hyperalgesia/etiology , Neural Conduction , Nociception/physiology , Paresthesia/etiology , Sodium Channels , TemperatureABSTRACT
Serious investigators of fibromyalgia (FM) realize the profound implications of finding features of small fiber neuropathy (SFN) in this disorder. For the first time, an easily reproducible and generally agreed upon, peripheral tissue lesion has been reported from multiple investigative centers. Understanding how this discovery relates to other features of FM, and how one might utilize it to better comprehend, and care for, afflicted patients' painful complaints remains a challenge, however. In this article we review how the SFN seen in FM may be placed in context, and suggest how such a tissue abnormality might be used to better understand the pathophysiology of FM, and plan for its effective treatment. We also suggest how finding SFN in FM implies the need for continued focused research within the area of neuropathic disease in FM.
Subject(s)
Autonomic Nervous System , Erythromelalgia/complications , Fibromyalgia/physiopathology , Neuralgia/etiology , Neuralgia/physiopathology , Autonomic Nervous System/pathology , Autonomic Nervous System/physiopathology , Erythromelalgia/pathology , Erythromelalgia/physiopathology , Fibromyalgia/complications , Fibromyalgia/pathology , Humans , Sensory Receptor Cells/pathologyABSTRACT
Erythromelalgia is a rare clinical syndrome characterized by erythema, increased temperature, and severe burning pain that can be aggravated by warmth or relieved by cold. Erythromelalgia occurs either as a primary, idiopathic form, or secondary to a number of diseases and conditions. Although fairly well studied in adults, the characteristics, pathogenesis, and natural history are poorly characterized in the pediatric age group. Different therapeutic options have been tried, but no optimal treatment has been suggested for erythromelalgia. We report a rare case of linear erythromelalgia in a 12-year-old girl involving her central body from the peripheral extremities, which seemed to be secondary due to vasculitis. Clinical progress waxed and waned on maintenance aspirin and propranolol.
Subject(s)
Aspirin/therapeutic use , Erythromelalgia/diagnosis , Pain/etiology , Propranolol/therapeutic use , Vasculitis/complications , Adrenergic beta-Antagonists/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Child , Drug Therapy, Combination , Erythromelalgia/complications , Erythromelalgia/drug therapy , Female , Humans , Pain/diagnosis , Pain/drug therapy , Vasculitis/drug therapyABSTRACT
Erythermalgia is a very rare acrosyndrome mainly characterized by lower limbs pain. It is either primitive or secondary. Concomittence of erythermalgia and diabetes is a coincidence and since the latter induces neuropathic and vascular lesions, erythermalgia is then considered as a consequence. We report the case of a young type 1 diabetic patient who presents with severe form of erythermalgia. Through this case report and a review of the literature, we shall explain the etiopathogenic mecanisms involved in erythermalgia in a diabetic patient and highlight the diagnosis and management challenges.
Subject(s)
Diabetes Mellitus, Type 1/complications , Erythromelalgia/diagnosis , Erythromelalgia/therapy , Adult , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Consanguinity , Diagnosis, Differential , Epilepsy/complications , Erythromelalgia/complications , Erythromelalgia/drug therapy , Erythromelalgia/genetics , Humans , Leg/pathology , Male , Myalgia/etiology , Risk Factors , Treatment OutcomeABSTRACT
OBJECTIVE: Painful small fibre neuropathy (SFN) represents a significant public health problem, with no cause apparent in one-half of cases (termed idiopathic, I-SFN). Gain-of-function mutations of sodium channel NaV1.7 have recently been identified in nearly 30% of patients with biopsy-confirmed I-SFN. More recently, gain-of-function mutations of NaV1.8 have been found in patients with I-SFN. These NaV1.8 mutations accelerate recovery from inactivation, enhance the response to slow depolarisations, and enhance activation at the channel level, thereby producing hyperexcitability of small dorsal root ganglion (DRG) neurons, which include nociceptors, at the cellular level. Identification and functional profiling of additional NaV1.8 variants are necessary to determine the spectrum of changes in channel properties that underlie DRG neuron hyperexcitability in these patients. METHODS: Two patients with painful SFN were evaluated by skin biopsy, quantitative sensory testing, nerve conduction studies, screening of genomic DNA for mutations in SCN9A and SCN10A and electrophysiological functional analysis. RESULTS: A novel sodium channel NaV1.8 mutation G1662S was identified in both patients. Voltage-clamp analysis revealed that the NaV1.8/G1662S substitution impairs fast-inactivation, depolarising the midpoint (V1/2) by approximately 7 mV. Expression of G1662S mutant channels within DRG neurons rendered these cells hyperexcitable. CONCLUSIONS: We report for the first time a mutation of NaV1.8 which impairs inactivation, in patients with painful I-SFN. Together with our earlier results, our observations indicate that an array of NaV1.8 mutations, which affect channel function in multiple ways, can contribute to the pathophysiology of painful peripheral neuropathy.
Subject(s)
Erythromelalgia/genetics , Erythromelalgia/physiopathology , Ganglia, Spinal/physiopathology , Mutation/genetics , NAV1.8 Voltage-Gated Sodium Channel/genetics , Erythromelalgia/complications , Female , Humans , Middle Aged , NAV1.7 Voltage-Gated Sodium Channel/genetics , Patch-Clamp Techniques , Young AdultABSTRACT
INTRODUCTION: Fibromyalgia (FM) is a chronic syndrome characterized by widespread pain often accompanied by other symptoms suggestive of neuropathic pain. We evaluated patients for small fiber neuropathy (SFN) who were referred for fibromyalgia (FM). METHODS: We studied 20 consecutive subjects with primary FM. Patients underwent neurological examination, nerve conduction studies, and skin biopsies from distal leg and thigh. RESULTS: Electrodiagnostic studies were normal in all patients. SFN was diagnosed in 6 patients by reduced epidermal nerve fiber density. These patients also showed abnormalities of both adrenergic and cholinergic fibers. CONCLUSIONS: A subset of FM subjects have SFN, which may contribute to their sensory and autonomic symptoms. Skin biopsy should be considered in the diagnostic work-up of FM.
Subject(s)
Adrenergic Neurons/pathology , Cholinergic Neurons/pathology , Electrodiagnosis , Erythromelalgia/pathology , Fibromyalgia/pathology , Nerve Fibers/pathology , Skin/pathology , Adult , Biopsy , Cohort Studies , Erythromelalgia/complications , Erythromelalgia/physiopathology , Female , Fibromyalgia/complications , Fibromyalgia/physiopathology , Humans , Leg/innervation , Male , Middle Aged , Neural Conduction/physiology , Neurologic Examination , Skin/innervationABSTRACT
BACKGROUND: Alcohol-related peripheral neuropathy (ALN) is generally characterized as an axonal large-fiber polyneuropathy caused by thiamine deficiency. We hypothesized, based on clinical observations, that ALN is associated with a small-fiber polyneuropathy that can be diagnosed with skin biopsy in heavy alcohol drinking subjects with normal thiamine status. METHODS: Eighteen individuals (9 heavy alcohol drinking subjects and 9 healthy control subjects) were assessed for the potential utility of skin biopsies in detecting ALN-associated small nerve fiber degeneration. Heavy drinking was defined as greater than 4 drinks/d and 5 drinks/d in women and men, respectively, as determined by the Timeline Follow-Back and lifetime drinking history. All subjects underwent neurological examination, nerve conduction studies, and skin biopsies to quantify end nerve fiber densities (ENFD). Other causes of neuropathy were excluded and thiamine status was assessed. RESULTS: Average ENFD were significantly decreased at the calf in the alcohol group as compared with control group (p < 0.0001). Histological sections demonstrated striking attrition and architectural simplification of intraepidermal nerve fibers in the heavy alcohol drinking subjects. There were no significant intergroup differences with respect to clinical assessments of neuropathy or thiamine status. CONCLUSIONS: ALN is associated with a small-fiber neuropathy that can be detected with skin biopsy in heavy alcohol drinking individuals with normal thiamine status. Skin biopsy is a useful, minimally invasive biomarker that could extend studies to understand the effect of alcohol on the peripheral nerves and to evaluate potential therapeutic agents in larger clinical trials.
Subject(s)
Alcohol Drinking/pathology , Alcoholic Neuropathy/pathology , Erythromelalgia/pathology , Skin/pathology , Adult , Alcohol Drinking/blood , Alcoholic Neuropathy/blood , Alcoholic Neuropathy/complications , Alcoholic Neuropathy/diagnosis , Biopsy , Case-Control Studies , Diagnostic Techniques, Neurological , Erythromelalgia/blood , Erythromelalgia/chemically induced , Erythromelalgia/complications , Erythromelalgia/diagnosis , Female , Humans , Male , Middle Aged , Neural Conduction/drug effects , Pilot Projects , Thiamine Pyrophosphate/blood , Young AdultABSTRACT
OBJECTIVE: Erythromelalgia is a rare clinical syndrome characterized by episodic attacks of burning pain, erythema, and increased temperature, primarily affecting the extremities, and in rare instances, involving the ear, face, neck, and the scrotum. The dermatoscopic features of erythromelalgia in a case with solely facial involvement have never been described previously. OBSERVATIONS: We describe a 14-year-old female who presented with erythema, burning sensation, and warmth on her face only, which mimic the features of erythromelalgia. Physical examination showed higher temperature on the involved cheeks than on axillas during the episode, while the temperature on both areas was the same between episodes. Dermatoscope showed more dilated vessels inside the erythema during the episodes than between the episodes. The symptoms had excellent response to the combination treatment of gabapentin, indomethacin, and topical lidocaine compounds. CONCLUSIONS: The present case is considered to be a variant of erythromelalgia. Its erythema may be resulted from the dilated vessels. Combination of modalities may provide effective management for erythromelalgia. "Erythermalgia" may be better than "erythromelalgia" to describe such conditions.
Subject(s)
Erythema/diagnosis , Erythromelalgia/diagnosis , Facial Pain/diagnosis , Pain/diagnosis , Adolescent , Erythema/complications , Erythromelalgia/complications , Facial Pain/complications , Female , Humans , Pain/complications , RecurrenceABSTRACT
Erythromelalgia is a rare disorder that simulates a small fiber neuropathy and patients often have painful erythematous extremities during episodes. It is of two types: A primary or inherited form that is sometimes associated with a Na channel mutation or a secondary disorder associated with an underlying systemic disorder. We present a 19-year-old boy who presented to us with erythromelalgia and a febrile illness with systemic rash. Detailed work-up revealed another unusual condition: Subcutaneous panniculitis like T cell lymphoma (SPTCL). This is the first report of an association of erythromelalgia with SPTCL.